Advanced Oncology Treatment Candidates Developed With Next-Generation Preclinical Models
Despite the significant progress made in oncology drug development over the last few decades, developers still face substantial challenges in delivering efficacious treatments.
One factor that can significantly impact the success of oncology drug development is the preclinical model used. The right model can provide valuable insights into key interactions within the body and help researchers to better understand how tumors respond to treatment.
Download this whitepaper to learn more about:
- How to find the right preclinical model
- The advantages of humanized immune system mouse models over traditional mouse models
- Accelerating the development of cancer treatments